MARKET

BIO

BIO

Bio Rad
NYSE

Real-time Quotes | Nasdaq Last Sale

355.89
+1.76
+0.50%
After Hours: 355.89 0 0.00% 16:24 11/15 EST
OPEN
355.58
PREV CLOSE
354.13
HIGH
357.60
LOW
354.68
VOLUME
136.89K
TURNOVER
--
52 WEEK HIGH
358.89
52 WEEK LOW
220.05
MARKET CAP
10.65B
P/E (TTM)
33.73
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BIO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BIO News

  • The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
  • Benzinga.1d ago
  • The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
  • Benzinga.3d ago
  • Does Bio-Rad Laboratories (NYSE:BIO) Have A Healthy Balance Sheet?
  • Simply Wall St..5d ago
  • 10X Genomics: Little Droplets Of Information
  • Seeking Alpha - Article.11/08 15:05

More

Industry

Medical Equipment, Supplies & Distribution
+1.05%
Healthcare Equipment & Supplies
+1.69%

Hot Stocks

Name
Price
%Change

About BIO

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. As of December 31, 2016, Bio-Rad sold more than 8,000 products and services to a client base, including scientific research, healthcare, education and government customers around the world.
More

Webull offers Bio-Rad Laboratories, Inc. (BIO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.